The Alzheimer’s Disease Diagnostic Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Alzheimer’s Disease Diagnostic Market?
The market size of Alzheimer's disease diagnostics has seen a swift increase in recent years. The market is projected to rise from $6.56 billion in 2024 to $7.28 billion in 2025, with a compound annual growth rate (CAGR) of 11%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Alzheimer’s Disease Diagnostic Industry?
The projected size of the Alzheimer’s Disease Diagnostic Global Market for 2029 is estimated to reach $10.91 billion, with a CAGR of 10.7%.
Download Your Free Sample of the 2025 Alzheimer’s Disease Diagnostic Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Alzheimer’s Disease Diagnostic Market?
The key drivers in the alzheimer’s disease diagnostic market are:
• Development of blood-based biomarkers for non-invasive diagnosis
• Rising demand for personalized medicine and precision diagnostics
• Integration of AI and machine learning in diagnostic tools for early detection
• Growing adoption of digital health technologies for remote monitoring and diagnosis.
Global Market Segmentation: Identifying Major Alzheimer’s Disease Diagnostic Industry Segments
The alzheimer’s disease diagnostic market covered in this report is segmented –
1) By Type: Triage, Diagnosis, Screening
2) By Diagnostic Technique: Biomarkers, Imaging Techniques, Genetic Testing, Cognitive Assessment Tests
3) By End User: Clinics, Hospitals, Diagnostic Centers, Pharmaceutical Companies, Academic Research Center
Subsegments:
1) By Triage: Cognitive Testing, Imaging Techniques
2) By Diagnosis: Biomarker Testing, Neuroimaging
3) By Screening: Neuropsychological Testing, Genetic Testing
Pre-order the 2025 Alzheimer’s Disease Diagnostic Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Alzheimer’s Disease Diagnostic Market?
The key trends in the alzheimer’s disease diagnostic market are:
• The development of blood-based biomarkers for non-invasive diagnosis is a rising trend.
• The demand for personalized medicine and precision diagnostics is influencing the market.
• Integration of AI and machine learning in diagnostic tools for early detection is an emerging trend.
• The adoption of digital health technologies for remote monitoring and diagnosis is shaping the future market.
Who Are the Top Competitors & Leading Players in the Alzheimer’s Disease Diagnostic Market?
Major players in the alzheimer’s disease diagnostic market are:
• Pfizer Inc.
• AbbVie
• Bristol Myers Squibb Company
• Hoffmann-La Roche
• Eli Lilly and Company
• Siemens Healthineers AG
• Laboratory Corporation of America Holdings
• Quest Diagnostics Incorporated
• Daiichi Sankyo Co.
• Sysmex
• Lantheus
• Quanterix
• FujireBio
• TauRx Pharmaceuticals Ltd
• AC Immune
• C2N Diagnostics
• AXON Neuroscience
• Neuro-Bio Ltd
• Anavex Life Sciences Corp.
• Treventis Corporation
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the alzheimer's disease diagnostic market in 2024
